Mescaline

Psychedelic

Mescaline is a long-acting, naturally occurring psychedelic of the phenethylamine family, found in cacti such as peyote and San Pedro and also made synthetically. It produces rich visual and emotional effects over 10–12 hours and has one of the longest documented histories of ceremonial use of any psychedelic.

Also known as: 3,4,5-trimethoxyphenethylamine, Mescaline sulfate, Mescaline HCl, Peyote (Lophophora williamsii), San Pedro / wachuma (Trichocereus), Mescalito

Written by Psymerge Editorial Team · Last updated June 4, 2026

Key facts

CategoryPsychedelic
Onset45–90 minutes
Peak2–4 hours
Total duration10–12 hours
After-effectsTiredness and a gentle afterglow into the next day

Overview

Mescaline (3,4,5-trimethoxyphenethylamine) is a classic serotonergic psychedelic. Unlike psilocybin, LSD, and DMT, which are tryptamines, mescaline is a phenethylamine, but it shares their main target: it acts primarily as an agonist at serotonin 5-HT2A receptors (Cassels & Sáez-Briones, 2018). It occurs naturally in several cacti — most notably North American peyote (Lophophora williamsii) and South American San Pedro or wachuma (Trichocereus species) — and can also be produced synthetically.

Mescaline is comparatively low in potency, so active doses are measured in hundreds of milligrams, and the experience is long: onset is gradual over 45–90 minutes and effects can last 10–12 hours. Users often describe it as warm, colourful, and emotionally open, with a strong sense of connection to nature.

Archaeological evidence suggests mescaline-containing cacti have been used for more than 6,000 years, giving the substance a uniquely deep and continuous ceremonial history (Cassels & Sáez-Briones, 2018). This page summarises its pharmacology, effects, and risks, drawing on peer-reviewed literature and established harm-reduction resources.

History & origins

Archaeological evidence from the United States, Mexico, and Peru suggests that mescaline-containing cacti have been used for more than 6,000 years, making them among the oldest known psychedelics. Peyote has long been central to Indigenous traditions in North America, while San Pedro (wachuma) has a comparably ancient history in the Andes. Spanish chroniclers in the sixteenth century condemned these cacti and tried to suppress their use, but the traditions endured.

In the late 1800s peyote drew scientific attention; mescaline was isolated as its active alkaloid and its structure was confirmed by synthesis in 1929 (Cassels & Sáez-Briones, 2018). In the twentieth century mescaline influenced writers and researchers — famously Aldous Huxley's The Doors of Perception — and the Native American Church secured legal protection for sacramental peyote use in the United States. It remains a focus of renewed psychedelic research today.

Pharmacology & how it works

Mescaline is a classic serotonergic psychedelic whose effects are attributed mainly to agonism at 5-HT2A serotonin receptors; it also binds 5-HT1A and α2A receptors at similar concentrations (Cassels & Sáez-Briones, 2018). Chemically it is a phenethylamine rather than a tryptamine, but it shares the 5-HT2A target that defines the classic psychedelics.

Chemical class
Phenethylamine (classic serotonergic psychedelic)
Routes of administration
Oral (whole or dried cactus), Oral (cactus extract or tea), Oral (pure mescaline salt)
Tolerance
Tolerance builds with repeated use and is cross-tolerant with other 5-HT2A psychedelics, but it resets after a few days; there is no physical dependence.

Pharmacokinetics

Taken orally, mescaline comes on over 45–90 minutes, peaks at 2–4 hours, and lasts around 10–12 hours in total. It is comparatively low in potency — active doses are in the hundreds of milligrams — and is largely excreted unchanged in the urine, with its metabolites apparently not responsible for its psychedelic effects.

Effects

Physical Effects

  • Nausea and vomiting, especially when whole cactus is consumed
  • Increased heart rate and blood pressure
  • Pupil dilation
  • Sweating and changes in body temperature
  • Loss of appetite
  • Tremor or restlessness

Psychological Effects

  • Rich, colourful visual patterns and enhanced colour perception
  • A warm, emotionally open or euphoric mood
  • Deep introspection and shifting trains of thought
  • A strong sense of connection to nature and surroundings
  • A distorted sense of time
  • Anxiety or difficult emotions during challenging experiences

Spiritual Effects

  • Mystical or unitive experiences
  • Feelings of reverence, gratitude, and connection
  • A sense of communion with nature or the sacred, central to many ceremonial traditions

Dosage Information

Low: 100–200 mg (oral, pure mescaline)
Medium: 200–400 mg (oral, pure mescaline)
High: 400–700+ mg (oral, pure mescaline)

Figures are for pure mescaline taken orally; mescaline sulfate and hydrochloride salts differ in equivalent weight. When taken as cactus, the mescaline content varies enormously between species and individual plants, making dose very hard to judge. Educational only and not an endorsement of use.

Risks & safety

Contraindications

Mescaline raises heart rate and blood pressure and produces a very long altered state, so it is generally inadvisable for:

  • Cardiovascular conditions: heart disease, uncontrolled high blood pressure, or a history of stroke.
  • Psychiatric history: a personal or family history of psychosis, schizophrenia, or bipolar disorder, which serotonergic psychedelics can destabilise.
  • Use of serotonergic medications or lithium (see interactions below).
  • Pregnancy and breastfeeding.

Drug interactions

As a serotonergic psychedelic, mescaline can interact with several classes of medication.

  • Lithium: combining lithium with classic psychedelics has been associated with seizures and is considered particularly dangerous.
  • MAOIs: can intensify and prolong effects and raise the risk of serotonin toxicity.
  • SSRIs, SNRIs, and other serotonergic drugs: raise the risk of serotonin syndrome.
  • Stimulants: add cardiovascular strain.

This list is not exhaustive. Disclose all medications to a clinician before considering use.

Psychological distress & bad trips

Mescaline's very long duration means a difficult experience can be especially tiring and hard to wait out. Challenging episodes may involve anxiety, fear, confusion, or distressing emotional material, and nausea early in the experience can add to discomfort. A calm, supportive setting and a sober, trusted companion substantially reduce the risk of a difficult experience becoming harmful.

Rare but serious risks

Mescaline has a relatively wide safety margin and low physical toxicity, but risks are not zero:

  • Cardiovascular strain: raised heart rate and blood pressure can be dangerous for people with heart conditions.
  • A very long, demanding experience: 10–12 hours can be physically and mentally exhausting, and vomiting can lead to dehydration.
  • Accidents and impaired judgment over a long period increase the risk of injury.
  • Prolonged perceptual changes (HPPD) are uncommon but have been reported with psychedelics in general.
  • Dangerous drug interactions, especially with lithium (seizure risk) and serotonergic medications.

Vulnerable populations

Some groups face higher risk and should avoid mescaline:

  • People with a personal or family history of psychosis, schizophrenia, or bipolar disorder.
  • People with heart disease or uncontrolled high blood pressure.
  • People taking lithium, MAOIs, antidepressants, or other serotonergic medications.
  • Adolescents, whose brains are still developing.
  • Pregnant or breastfeeding people.

Dependency & addiction potential

Like other classic psychedelics, mescaline is not considered addictive. It does not produce physical dependence or compulsive use, and tolerance fades after a few days of abstinence. Notably, a study of Native American Church members who used peyote regularly over many years found no evidence of lasting psychological or cognitive deficits (Halpern et al., 2005).

Overdose

Mescaline has a wide safety margin, and there is no well-established lethal dose in humans; serious toxicity and death are very rare and usually involve other drugs or pre-existing medical conditions. The main acute dangers are cardiovascular strain, dehydration from vomiting, and accidents during the long experience. If someone develops chest pain, a dangerously high heart rate, seizures, a very high temperature with muscle rigidity (possible serotonin syndrome), or loss of consciousness, seek emergency medical help immediately.

Harm Reduction

  • Start low and wait: onset is slow (45–90 minutes), and cactus material varies widely in strength, so do not redose early.
  • Set aside a full day and a safe, comfortable environment, since effects last 10–12 hours.
  • Have a sober, trusted sitter present, and never use alone.
  • Avoid combining with lithium, MAOIs, SSRIs, or other serotonergic medications — the lithium combination in particular has been linked to seizures.
  • Expect nausea: eat lightly beforehand and stay hydrated throughout.
  • Avoid mescaline if you have a heart condition or a personal or family history of psychosis.
  • Respect Indigenous traditions and conservation: peyote is slow-growing and threatened by over-harvesting, so consider sustainably grown San Pedro or synthetic mescaline instead of wild peyote.

Cultural & spiritual context

Mescaline has one of the deepest and most continuous ceremonial lineages of any psychedelic. Peyote is a sacrament of the Native American Church and of peoples such as the Wixárika (Huichol) of Mexico, while San Pedro (wachuma) has been used by Andean cultures for millennia. These are living traditions, not historical curiosities, and they carry specific protocols, meanings, and community responsibilities.

Two issues deserve particular respect. First, conservation: peyote is slow-growing and is increasingly threatened by over-harvesting and habitat loss, which is why many advocates encourage sustainably cultivated San Pedro or synthetic mescaline rather than wild peyote. Second, cultural respect: peyote's sacramental use is legally protected for Native American Church members in the US, and Indigenous communities have asked that outsiders not deplete this sacred and limited resource.

Legal Status

Laws vary widely by country and change frequently, so we don't track legal status here to avoid showing outdated information.

Check current worldwide legal status on Psychedelic Alpha

Frequently asked questions

How long does a mescaline experience last?

Mescaline is long-acting. Taken orally, it comes on gradually over 45–90 minutes, peaks at around 2–4 hours, and lasts roughly 10–12 hours in total, with tiredness and a gentle afterglow often continuing into the next day.

Is mescaline addictive?

No. Like other classic psychedelics, mescaline does not cause physical dependence or compulsive use, and tolerance fades after a few days. A study of long-term ceremonial peyote use among Native American Church members found no evidence of lasting psychological or cognitive deficits (Halpern et al., 2005).

Why do peyote and San Pedro often cause vomiting?

Nausea and vomiting are common physical effects of consuming the whole cactus, which is bitter and contains other alkaloids. In several ceremonial traditions this purging is regarded as a natural and even meaningful part of the experience.

Is peyote endangered?

Peyote is slow-growing and increasingly threatened by over-harvesting and habitat loss. Its sacramental use is legally protected for Native American Church members in the US, and conservation advocates encourage using sustainably cultivated San Pedro or synthetic mescaline rather than depleting wild peyote.

Is it dangerous to combine mescaline with antidepressants or lithium?

It can be. Combining classic psychedelics with lithium has been linked to seizures, and MAOIs, SSRIs, and other serotonergic drugs can raise the risk of serotonin toxicity. Any decision about stopping prescribed medication should be made only with a clinician.

Need Integration Support?

Connect with qualified integration guides who can help you process and integrate your experiences safely and effectively.

Find a Guide

Related substances

2C-B

Psychedelic

2C-B is a synthetic psychedelic phenethylamine first made by Alexander Shulgin and structurally related to mescaline. It is strongly dose-dependent: lower doses feel warm, sensual, and entactogen-like (similar to MDMA), while higher doses are clearly psychedelic, with effects lasting about 4–8 hours.

4-AcO-DMT

Psychedelic

4-AcO-DMT (psilacetin, O-acetylpsilocin) is a synthetic tryptamine that acts as a prodrug for psilocin — the same active compound produced by magic mushrooms. Its effects are widely reported to be very similar to psilocybin.

5-MeO-DMT

Psychedelic

5-MeO-DMT is an extremely potent, fast-acting psychedelic tryptamine found in the venom of the Sonoran Desert toad and in some plants, and also made synthetically. Rather than the rich visuals of DMT, it tends to produce a sudden, overwhelming experience of ego dissolution and oneness lasting only minutes.

3-MMC

Synthetic

3-MMC (3-methylmethcathinone) is a synthetic cathinone and 'research chemical' closely related to mephedrone. It is a short-acting stimulant with mild entactogenic effects, a strong tendency to drive compulsive redosing, and significant risks including cardiovascular toxicity and dependence.

References & further reading

  • Cassels, B. K., & Sáez-Briones, P. (2018). Dark Classics in Chemical Neuroscience: Mescaline. ACS Chemical Neuroscience, 9(10), 2448–2458. https://doi.org/10.1021/acschemneuro.8b00215
  • Halpern, J. H., Sherwood, A. R., Hudson, J. I., Yurgelun-Todd, D., & Pope, H. G., Jr. (2005). Psychological and Cognitive Effects of Long-Term Peyote Use Among Native Americans. Biological Psychiatry, 58(8), 624–631. https://doi.org/10.1016/j.biopsych.2005.06.038
  • Nichols, D. E. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264–355. https://doi.org/10.1124/pr.115.011478
  • National Institute on Drug Abuse (NIDA). Psychedelic and Dissociative Drugs. https://nida.nih.gov/research-topics/psychedelic-dissociative-drugs
  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Drug profiles. https://www.emcdda.europa.eu/publications/drug-profiles_en
  • Erowid. Mescaline Vault. https://www.erowid.org/chemicals/mescaline/
  • DanceSafe. https://dancesafe.org/drug-information/
  • TripSit. Drug combinations chart. https://wiki.tripsit.me/wiki/Drug_combinations

About this article

Written by:
PE
Psymerge Editorial Team
Last updated June 4, 2026